Stephen R. Goding

408 total citations
10 papers, 319 citations indexed

About

Stephen R. Goding is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Stephen R. Goding has authored 10 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 2 papers in Genetics. Recurrent topics in Stephen R. Goding's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (4 papers). Stephen R. Goding is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (4 papers). Stephen R. Goding collaborates with scholars based in United States, Denmark and Cuba. Stephen R. Goding's co-authors include Paul A. Antony, Per Basse, Kyle Wilson, Qin Yang, Kristina M. Harris, Scott E. Strome, Marianne Hokland, Koji Tamada, Ying Xie and Akgül Akpınarlı and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Human Gene Therapy.

In The Last Decade

Stephen R. Goding

10 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen R. Goding United States	9	236	211	39	18	13	10	319
Tatsuhiko Suwa Japan	7	337 1.4×	161 0.8×	79 2.0×	21 1.2×	7 0.5×	8	418
Stine Kiær Larsen Denmark	8	299 1.3×	235 1.1×	87 2.2×	28 1.6×	17 1.3×	14	421
Kangling Xu United States	3	174 0.7×	130 0.6×	81 2.1×	8 0.4×	7 0.5×	7	309
Dennis Clement Norway	5	286 1.2×	181 0.9×	41 1.1×	18 1.0×	34 2.6×	7	340
Liberty Posada United States	4	130 0.6×	122 0.6×	74 1.9×	22 1.2×	23 1.8×	5	238
Jasper N. Prüßmann United States	4	219 0.9×	141 0.7×	65 1.7×	21 1.2×	5 0.4×	5	326
Sunny Mai United States	7	211 0.9×	93 0.4×	101 2.6×	22 1.2×	8 0.6×	8	322
I Montalban del Barrio Germany	5	224 0.9×	175 0.8×	104 2.7×	14 0.8×	8 0.6×	5	412
George A. Dominguez United States	5	198 0.8×	126 0.6×	73 1.9×	27 1.5×	10 0.8×	12	279
Adriana C. De La Fuente United States	4	302 1.3×	199 0.9×	129 3.3×	13 0.7×	9 0.7×	4	407

Countries citing papers authored by Stephen R. Goding

Since Specialization

Citations

This map shows the geographic impact of Stephen R. Goding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen R. Goding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen R. Goding more than expected).

Fields of papers citing papers by Stephen R. Goding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen R. Goding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen R. Goding. The network helps show where Stephen R. Goding may publish in the future.

Co-authorship network of co-authors of Stephen R. Goding

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen R. Goding. A scholar is included among the top collaborators of Stephen R. Goding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen R. Goding. Stephen R. Goding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Goding, Stephen R., et al.. (2018). PD-L1–Independent Mechanisms Control the Resistance of Melanoma to CD4+ T Cell Adoptive Immunotherapy. The Journal of Immunology. 200(9). 3304–3311. 11 indexed citations

Jiang, Shunlin, Emmanual Unni, Stephen R. Goding, et al.. (2018). 17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model. PLoS ONE. 13(2). e0191264–e0191264. 15 indexed citations

Goding, Stephen R., et al.. (2016). Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells. Clinical Immunology. 177. 76–86. 12 indexed citations

Wilson, Kyle, Stephen R. Goding, Harold R. Neely, Kristina M. Harris, & Paul A. Antony. (2015). Depletion of B220⁺NK1.1⁺cells enhances the rejection of established melanoma by tumor-specific CD4⁺T cells. OncoImmunology. 4(8). e1019196–e1019196. 10 indexed citations

Goding, Stephen R., Kyle Wilson, Ying Xie, et al.. (2013). Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma. The Journal of Immunology. 190(9). 4899–4909. 161 indexed citations

Goding, Stephen R., Kyle Wilson, & Paul A. Antony. (2013). Combination of adoptive cell transfer, anti-PD-L1 and anti-LAG-3 antibodies for the treatment of recurrent tumors. OncoImmunology. 2(8). e25050–e25050. 5 indexed citations

Goding, Stephen R., Qin Yang, Mi Zhang, Paul D. Robbins, & Per Basse. (2007). Targeting of products of genes to tumor sites using adoptively transferred A-NK and T-LAK cells. Cancer Gene Therapy. 14(5). 441–450. 12 indexed citations

Goding, Stephen R., Qin Yang, Kristina Bram Knudsen, Douglas M. Potter, & Per Basse. (2007). Cytokine Gene Therapy Using Adenovirally Transduced, Tumor-Seeking Activated Natural Killer Cells. Human Gene Therapy. 18(8). 701–711. 14 indexed citations

Yang, Qin, Stephen R. Goding, Marianne Hokland, & Per Basse. (2006). Antitumor Activity of NK Cells. Immunologic Research. 36(1-3). 13–26. 54 indexed citations

10.

Yang, Qin, Stephen R. Goding, Timothy M. Carlos, et al.. (2005). Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells. Cancer Immunology Immunotherapy. 55(6). 699–707. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact